Basics Organogenesis Holdings Inc. IPO Date: January 2, 2017 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $601.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 3.60% Avg Daily Range (30 D): $0.17 | 3.31% Avg Daily Range (90 D): $0.14 | 2.88% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): 1.91M Avg Daily Volume (90 D): 1M Trade Size Avg Trade Size (Sh.): 115 Avg Trade Size (Sh.) (30 D): 111 Avg Trade Size (Sh.) (90 D): 107 Institutional Trades Total Inst.Trades: 877 Avg Inst. Trade: $2.32M Avg Inst. Trade (30 D): $1.91M Avg Inst. Trade (90 D): $2.14M Avg Inst. Trade Volume: .36M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.09M Avg Closing Trade (30 D): $.66M Avg Closing Trade (90 D): $.73M Avg Closing Volume: 260.33K     News Nov 20, 2025 @ 6:00 PM Global Wound Healing Devices Market Poised for Rob... Source: Delveinsight Oct 17, 2025 @ 6:20 PM Organogenesis Holdings Inc. Investigated for Secur... Source: Business Wire Sep 26, 2025 @ 3:24 PM Why Is Organogenesis Stock Trading Lower Friday? Source: Vandana Singh Sep 25, 2025 @ 9:06 PM 12 Health Care Stocks Moving In Thursday's After-M... Source: Benzinga Staff Writer Sep 25, 2025 @ 8:50 PM Organogenesis Provides Update on Second Phase 3 Re... Source: Organogenesis Holdings Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $.11 $-.1 Diluted EPS $.11 $-.1 Revenue $ $ 150.86M $ 101.01M Gross Profit $ $ $ Net Income / Loss $ $ 21.57M $ -9.39M Operating Income / Loss $ $ 20.73M $ -12.58M Cost of Revenue $ $ $ Net Cash Flow $ $ -9.36M $ -36.8M PE Ratio